These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1563018)

  • 1. Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.
    Wright SC; Tam AW; Kumar P
    Cancer Immunol Immunother; 1992; 34(6):399-406. PubMed ID: 1563018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin.
    Hofsli E; Nissen-Meyer J
    Int J Cancer; 1989 Mar; 43(3):520-5. PubMed ID: 2925281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor necrosis factor on human tumor cell lines sensitive and resistant to cytotoxic drugs, and its interaction with chemotherapeutic agents.
    Soranzo C; Perego P; Zunino F
    Anticancer Drugs; 1990 Dec; 1(2):157-63. PubMed ID: 2131048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
    PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
    Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
    Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
    Chang NS
    Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants.
    Wright SC; Zheng H; Zhong J; Torti FM; Larrick JW
    J Cell Biochem; 1993 Nov; 53(3):222-33. PubMed ID: 8263039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs.
    Neale ML; Matthews N
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):133-7. PubMed ID: 2493381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
    Safrit JT; Berek JS; Bonavida B
    Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor induces activation of mitochondrial succinate dehydrogenase.
    Levrat C; Larrick JW; Wright SC
    Life Sci; 1991; 49(23):1731-7. PubMed ID: 1943475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ; Belldegrun A; Bonavida B
    Prostate; 1999 Sep; 41(1):20-30. PubMed ID: 10440872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
    Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
    Singh S; Raju U; Mendoza J; Pantazis P; Aggarwal BB
    Anticancer Drugs; 1998 Sep; 9(8):703-14. PubMed ID: 9823429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
    Ujhazy P; Chen YF; Fredericks W; Ho RL; Mihich E; Baker RM; Ehrke MJ
    Cancer Commun; 1990; 2(5):181-8. PubMed ID: 1973358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.
    Safrit JT; Bonavida B
    Cancer Immunol Immunother; 1992; 34(5):321-8. PubMed ID: 1540978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
    D'Alessandro N; Flugy A; Tolomeo M; Dusonchet L
    Anticancer Res; 1998; 18(4C):3065-72. PubMed ID: 9713511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.